DEF 14AThe Ballot
REGENERON PHARMACEUTICALS, INC. files DEF 14A
Filed Apr 23, 2018 · 8y ago · Accession 0001047469-18-003073
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- REGN
- CIK
- 872589
- Form type
- DEF 14A
- Filing date
- Apr 23, 2018
- Report date
- Jun 8, 2018
- Document
- a2234921zdef14a.htm
- Size
- 8.6 MB